Duchenne muscular dystrophy Pfizer

Pfizer to abort trials of Duchenne muscular dystrophy drug

Pfizer has decided to abort two of its ongoing clinical trials evaluating domagrozumab (PF-06252616) for the treatment of Duchenne muscular…